Updated on 2025/04/18
MD （ 2013.3 Nagoya University ）
nephrotic syndrome
nephrology
peripheral blood monocyte cells
multi-omics analysis
IgA nephritis
Life Science / Genome biology
Life Science / Nephrology
難治性腎疾患の治療最適化
Nagoya University Graduate School of Medicine Center for Research of Laboratory Animals and Medical Research Engineering Division for Advanced Medical Research Assistant Professor
2024.2
Nagoya University
2007.4 - 2013.3
日本遺伝カウンセリング学会
日本透析医学会
日本腎臓学会 SRチーム
日本内科学会 JMECCインストラクター
日本腎臓学会 「腎障害患者におけるヨード造影剤使用に関するガイドライン改訂委員会」 委員
2025.2
Committee type：Academic society
日本腎臓学会 学術委員会SRチーム
2018.4
Committee type：Academic society
腎障害患者におけるヨード造影剤使用に関するガイドライン2018
PKDガイドライン2020
CKDガイドライン2023
PKDガイドライン2026
日本女性腎臓病医の会（JSWN）研究活動奨励賞
2023.6 日本女性腎臓病医の会 微小変化型ネフローゼに対するリツキシマブ治療の作用機構の全容解明を目指して－ヒト末梢血白血球の網羅的解析を通して
奨励賞
2018.1 藤田医科大学医学部腎内科学同門会
第8回腎不全研究会特別奨励賞
2017.12 腎不全研究会
第19回名古屋大学医学部つるま賞
2013.3 名古屋大学
日本内科学会第218回東海地方会優秀演題賞
2012.10 日本内科学会 原発性膜性腎症の治療反応性に寄与する因子の検討
Urinary presepsin can efficiently detect T-cell-mediated rejection in patients who have undergone kidney transplantation Invited Reviewed Open Access
Clin Exp Nephrol. 2025.4
Urinary presepsin is a novel biomarker capable of directly assessing monocyte/macrophage infiltration in kidney diseases. Reviewed
Niwa S, Tanaka A, Furuhashi K, Hattori K, Onogi C, Sunohara K, Owaki A, Kato A, Kawazoe T, Watanabe Y, Koshi-Ito E, Kato N, Kosugi T, Maruyama S.
Scientific Reports Vol. 14 ( 1 ) page： 30088 2024.12
Association between alpha blocker use and the risk of fractures in patients with chronic kidney disease: a cohort study. Reviewed
Sunohara K, Onogi C, Tanaka A, Furuhashi K, Matsumoto J, Hattori K, Owaki A, Kato A, Kawazoe T, Watanabe Y, Koshi-Ito E, Maruyama S
BMC Nephrology Vol. 25 ( 1 ) page： 442 2024.12
Prognosis of microscopic polyangiitis is well predictable in the first 2 weeks of treatment Reviewed
Owaki A; Tanaka A; Kazuhiro Furuhashi; Watanabe Y; Koshi-Ito E; Imaizumi T; Maruyama S
Clinical and experimental nephrology Vol. 28 ( 7 ) page： 701 - 706 2024.7
Associations of time-dependent changes in phosphorus levels with cardiovascular diseases in patients undergoing hemodialysis: results from the Japan Dialysis Active Vitamin D (J-DAVID) randomized clinical trial. Reviewed
Koshi-Ito E, Inaguma D, Ishii H, Yuzawa Y, Kabata D, Shintani A, Inaba M, Emoto M, Mori K, Morioka T, Nakatani S, Shoji T
Clinical kidney journal Vol. 15 ( 12 ) page： 2281 - 2291 2022.12
Systematic characterization of seed overlap microRNA cotargeting associated with lupus pathogenesis. Reviewed
Kitai H, Kato N, Ogami K, Komatsu S, Watanabe Y, Yoshino S, Koshi E, Tsubota S, Funahashi Y, Maeda T, Furuhashi K, Ishimoto T, Kosugi T, Maruyama S, Kadomatsu K, Suzuki HI
BMC biology Vol. 20 ( 1 ) page： 248 2022.11
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020. Reviewed
Nishio S, Tsuchiya K, Nakatani S, Muto S, Mochizuki T, Kawano H, Hanaoka K, Hidaka S, Ichikawa D, Ishikawa E, Uchiyama K, Koshi-Ito E, Hayashi H, Makabe S, Ogata S, Mitobe M, Sekine A, Suwabe T, Kataoka H, Kai H, Kaneko Y, Kurashige M, Seta K, Shimazu K, Hama T, Miura K, Nakanishi K, Horie S, Furuichi K, Okada H, Narita I, Committee of Clinical Practical Guideline for Polycystic Kidney Disease 2020
Clinical and experimental nephrology Vol. 25 ( 12 ) page： 1292 - 1302 2021.12
Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis. Reviewed
Koshi-Ito E, Inaguma D, Koide S, Takahashi K, Hayashi H, Tsuboi N, Hasegawa M, Maruyama S, Yuzawa Y
Renal failure Vol. 43 ( 1 ) page： 1528 - 1538 2021.12
Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019. Reviewed
Koshi E, Saito S, Okazaki M, Toyama Y, Ishimoto T, Kosugi T, Hiraiwa H, Jingushi N, Yamamoto T, Ozaki M, Goto Y, Numaguchi A, Miyagawa Y, Kato I, Tetsuka N, Yagi T, Maruyama S
CEN case reports Vol. 10 ( 1 ) page： 126 - 131 2021.2
Extreme hyperuricemia is a risk factor for infection-related deaths in incident dialysis patients: a multicenter prospective cohort study. Reviewed
Yoshida H, Inaguma D, Koshi-Ito E, Ogata S, Kitagawa A, Takahashi K, Koide S, Hayashi H, Hasegawa M, Yuzawa Y, Tsuboi N
Renal failure Vol. 42 ( 1 ) page： 646 - 655 2020.11
Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Reviewed
Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, Yasuda Y, Japanese Society of Nephrology, Japan Radiological Society, and Japanese Circulation Society Joint Working Group
Clinical and experimental nephrology Vol. 24 ( 1 ) page： 1 - 44 2020.1
Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Reviewed
Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, Yasuda Y, Japanese Society of Nephrology, Japan Radiological Society, and Japanese Circulation Society Joint Working Group
Japanese journal of radiology Vol. 38 ( 1 ) page： 3 - 46 2020.1
Effect of Low-Density Lipoprotein Apheresis for Nephrotic Idiopathic Membranous Nephropathy as Initial Induction Therapy. Reviewed
Koshi-Ito E, Koike K, Tanaka A, Watanabe Y, Kamegai N, Shimogushi H, Shinjo H, Otsuka Y, Inaguma D, Takeda A
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy Vol. 23 ( 6 ) page： 575 - 583 2019.12
Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018. Reviewed
Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, Yasuda Y, Japanese Society of Nephrology, Japan Radiological Society, Japanese Circulation Society Joint Working Group
Circulation journal : official journal of the Japanese Circulation Society Vol. 83 ( 12 ) page： 2572 - 2607 2019.11
Relationship Between Patterns in Antihypertensive Drugs Medication and Mortality in Incident Dialysis Patients: A Multicenter Prospective Cohort Study. Reviewed
Fujii M, Inaguma D, Koide S, Ito E, Takahashi K, Hayashi H, Tsuboi N, Hasegawa M, Yuzawa Y
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy Vol. 23 ( 4 ) page： 353 - 361 2019.8
Relationship between History of Ischemic Stroke and All-Cause Mortality in Incident Dialysis Patients. Reviewed
Kojima M, Inaguma D, Koide S, Koshi-Ito E, Takahashi K, Hayashi H, Tsuboi N, Hasegawa M, Yuzawa Y
Nephron Vol. 143 ( 1 ) page： 43 - 53 2019
Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients. Reviewed
Inaguma D, Morii D, Kabata D, Yoshida H, Tanaka A, Koshi-Ito E, Takahashi K, Hayashi H, Koide S, Tsuboi N, Hasegawa M, Shintani A, Yuzawa Y
PloS one Vol. 14 ( 8 ) page： e0221352 2019
Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method. Reviewed
Ito E, Inaguma D, Koide S, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y
Clinical and experimental nephrology Vol. 22 ( 6 ) page： 1309 - 1314 2018.12
Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan. Reviewed
Inaguma D, Ito E, Takahashi K, Hayashi H, Koide S, Hasegawa M, Yuzawa Y, AICOPP Group
Clinical and experimental nephrology Vol. 22 ( 6 ) page： 1360 - 1370 2018.12
Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study. Reviewed
Owaki A, Inaguma D, Aoyama I, Inaba S, Koide S, Ito E, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y, AICOPP group
Renal failure Vol. 40 ( 1 ) page： 475 - 482 2018.11
Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis. Reviewed
Inaguma D, Sasakawa Y, Suzuki N, Ito E, Takahashi K, Hayashi H, Koide S, Hasegawa M, Yuzawa Y, Tokai Aortic Stenosis in Dialysis Patients Cohort Study Group
BMC nephrology Vol. 19 ( 1 ) page： 80 2018.4
Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study. Reviewed
Inaguma D, Koide S, Ito E, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y, AICOPP group
Clinical and experimental nephrology Vol. 22 ( 2 ) page： 353 - 364 2018.4
Combination Therapy with Renin-Angiotensin System Blockers and Vitamin D Receptor Activators for Predialysis Patients Is Associated with the Incidence of Cardiovascular Events after Dialysis Initiation: A Multicenter Nonrandomized Prospective Cohort Study. Reviewed
Inaguma D, Ito E, Koide S, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y
Cardiorenal medicine Vol. 8 ( 1 ) page： 71 - 81 2017.12
エビデンスに基づくCKD診療ガイドライン 2023 Reviewed
（ Role： Contributor , 11-9 CKD患者のシックデイにおける薬物の中止[丸山彰一, 小杉智規, 安田宜成, 西堀暢浩, 鈴木克彦, 武田有記, 古志衣里]）
東京医学社 2023.6 （ ISBN:9784885637414 ）
エビデンスに基づく多発性囊胞腎（PKD）診療ガイドライン2020 Reviewed
（ Role： Contributor , CQ2.ADPKDの治療にトルバプタンは推奨されるか？[林宏樹, 古志衣里, 尾形宗士郎]）
東京医学社 2020.8 （ ISBN:9784885637247 ）
腎障害患者におけるヨード造影剤使用に関するガイドライン2018 Reviewed
（ Role： Contributor）
東京医学社 2018.10 （ ISBN:9784885632952 ）
内科学書改訂第9版vol.3
南学正臣（ Role： Contributor , 7．尿細管間質性腎炎［湯澤由紀夫，稲熊大城，古志衣里］）
中山書店 2019.8 （ ISBN:978-4-521-74749-1 ）
糖尿病性腎臓病の診かた,考えかた
和田隆志 編著 ／ 柏原直樹 編著（ Role： Contributor , Ch. III 診断・バイオマーカー）
中外医学社 2018.6 （ ISBN:978-4-498-22436-0 ）
微小変化型ネフローゼに対するリツキシマブ治療の作用機構の全容解明を目指して―ヒト末梢血白血球の網羅的解析を通して― Invited
古志衣里
日本女性腎臓病医の会第21回総会 2024.6.8 日本女性腎臓病医の会
微小変化型ネフローゼに対するリツキシマブ治療の作用機構の全容解明を目指して―ヒト末梢血白血球の網羅的解析を通して― Invited
古志衣里
日本女性腎臓病医の会第20回総会（受賞講演） 2023.6.9
Early introduction of intravenous VDRA could be associated with better prognosis of end-stage kidney disease patients on hemodialysis International conference
the 55th ERA-EDTA Congress in Copenhagen, Denmark 2018.5.15
Efficacy of LDL apheresis for initial induction therapy of nephrotic membranous nephropathy International conference
Eri Koshi
the 54th ERA-EDTA Congress in Madrid, Spain 2017.6.4 ERA-EDTA
J-MARINE2 study
NNMAC
Comprehensive analysis of changes in peripheral blood induced by HIF-PH inhibitors
Comprehensive analysis of effects on peripheral blood cells induced by ADR-001 for IgA nephropathy
微小変化型ネフローゼに対するリツキシマブの治療機序解明
Grant number：YRY-2412 2024.11
2024年度横山臨床薬理研究助成基金
Authorship：Principal investigator Grant type：Competitive
Grant amount：\1000000
ヒト末梢血白血球網羅的解析が解き明かす微小変化型ネフローゼ進行に関わる免疫学的機序
2023.8 - 2024.3
愛知腎臓財団研究助成費
Grant type：Competitive
Grant amount：\200000
活性型ビタミンDと炭酸ランタンとの併用が血清FGF23濃度に与える影響に関する研究
2018.4 - 2019.3
愛知腎臓財団研究助成費
Grant type：Competitive
Grant amount：\250000
活性型ビタミンDと炭酸ランタンとの併用が血清FGF23濃度に与える影響に関する研究
2018.4 - 2019.3
日本腎臓財団公募助成（腎不全病態研究助成）
Authorship：Principal investigator Grant type：Competitive
Grant amount：\600000
Elucidation of the Immune Regulatory Mechanisms Involved in the Treatment and Responsiveness of IgA Nephropathy Using Multi-Omics Analysis
Grant number：24K23431 2024.9
Authorship：Principal investigator Grant type：Competitive
Grant amount：\2860000 （ Direct Cost: \2200000 、 Indirect Cost：\660000 ）
難治性の希少腎疾患に対する治療最適化に向けた研究開発
Grant number：24ek0109753h0001 2024.4
国立研究開発法人 日本医療研究開発機構 令和6年度「難治性疾患実用化研究事業」
Authorship：Coinvestigator(s) Grant type：Competitive
Grant amount：\97500000 （ Direct Cost: \75000000 、 Indirect Cost：\22500000 ）
腎臓内科学
2024
